N3-kethoxal: Guanine-Accessible Nucleic Acid Mapping

Executive Summary. N3-kethoxal is described as a synthetic, membrane-permeable nucleic acid probe that reacts selectively with unpaired guanine bases in RNA and single-stranded DNA regions (product information). The reaction forms a stable covalent adduct that introduces an azide functional group for subsequent bioorthogonal click chemistry labeling (product information). The related CasKAS study established chemical mapping of unwound single-stranded DNA structures formed by CRISPR binding in both in vitro and in vivo contexts (Marinov et al., 2023). The product listing reports a molecular weight of 189.17 g/mol, a formula of C6H11N3O4, and a purity of 98% (product information).

Biological Rationale

Nucleic-acid structure controls recognition, processing, localization, and interaction. A guanine base can be more chemically accessible when it is unpaired, exposed in a loop, present in a bulge, or located in an unwound nucleic-acid segment. A probe that records this accessibility can convert a transient structural state into a covalent molecular mark.

N3-kethoxal is designed around that principle. Its stated selectivity for unpaired guanine creates a chemical readout of accessibility rather than a generic stain for total RNA or DNA. In RNA, the readout can inform RNA secondary structure probing and analysis of higher-order conformations. In DNA, the same accessibility concept can support genomic mapping of accessible DNA regions when the experimental design generates or captures single-stranded segments. These uses are product-described applications, not a guarantee that every guanine-containing sequence will react equally (product information).

The CasKAS reference provides a complementary methodological rationale. Cas9 or dCas9 binding can create an unwound single-stranded DNA structure. CasKAS chemically maps that structure to profile binding and cleavage specificity. The study addresses CRISPR off-target detection, including catalytically active and catalytically dead CRISPR enzymes, rather than serving as a direct validation study of every N3-kethoxal application (Marinov et al., 2023).

Mechanism of Action of N3-kethoxal

The listed chemical name is 3-(2-azidoethoxy)-1,1-dihydroxybutan-2-one. The molecule contains an azide functional group and a kethoxal-derived reactive region. The product description states that the probe reacts with unpaired guanine bases in RNA and single-stranded DNA regions to form stable covalent adducts (product information).

The mechanism has two functional stages. First, the probe recognizes a chemically accessible guanine. Second, the resulting nucleic-acid adduct retains an azide handle. The azide does not itself define the final detection modality. Instead, it provides a programmable attachment point for a compatible bioorthogonal click chemistry reagent. The investigator can therefore connect the original structural mark to a fluorophore, affinity tag, sequencing-compatible group, or another validated click partner. The exact reporter, catalyst, reaction time, and purification scheme must be selected for the assay and verified experimentally.

This design separates molecular recognition from signal generation. Guanine accessibility determines where labeling can occur. Click chemistry determines how the mark becomes measurable. That separation can be useful in workflows that require imaging, enrichment, sequencing, or interaction capture. It also creates a critical control requirement: a click signal is interpretable only when probe exposure, click-reagent background, and untreated controls are assessed in parallel.

N3-kethoxal is supplied as a liquid. The product page lists the formula C6H11N3O4 and molecular weight 189.17 g/mol. It also reports high minimum solubilities of 94.6 mg/mL in DMSO, 24.6 mg/mL in water, and 30.4 mg/mL in ethanol. The public listing does not specify the temperature, pH, or assay format used for those solubility measurements, so these values should guide solvent screening rather than replace a formulation test (product information).

Evidence & Benchmarks

The following benchmarks distinguish product-described capabilities from findings in the peer-reviewed CasKAS reference. They should not be interpreted as head-to-head performance comparisons.

• 1. Chemical accessibility mapping: CasKAS maps unwound single-stranded DNA structures generated during CRISPR-protein binding through chemical modification and sequencing-based analysis. https://doi.org/10.1186/s13059-023-02930-z
• 2. Biological scope: The CasKAS study demonstrates the approach in both in vitro and in vivo contexts. https://doi.org/10.1186/s13059-023-02930-z
• 3. CRISPR specificity: CasKAS was introduced for profiling binding and cleavage specificity of active Cas9 and catalytically dead CRISPR enzymes. https://doi.org/10.1186/s13059-023-02930-z
• 4. Product identity: The N3-kethoxal listing identifies CAS 2382756-48-9, the chemical name 3-(2-azidoethoxy)-1,1-dihydroxybutan-2-one, formula C6H11N3O4, and molecular weight 189.17 g/mol. https://www.apexbt.com/n3-kethoxal.html
• 5. Product purity: The product information reports a purity of 98%. https://www.apexbt.com/n3-kethoxal.html
• 6. Solubility benchmarks: The listing reports minimum solubilities of 94.6 mg/mL in DMSO, 24.6 mg/mL in water, and 30.4 mg/mL in ethanol; the public page does not state measurement temperature or pH. https://www.apexbt.com/n3-kethoxal.html

Applications, Limits & Misconceptions

N3-kethoxal can be positioned as an azide-functionalized nucleic acid probe for several experimental objectives. In RNA secondary structure probing, the covalent mark can report guanine accessibility across alternative folds or interaction states. In genomic mapping of accessible DNA, it can target single-stranded regions created by local unwinding or other structural contexts. In RNA-RNA interaction studies, changes in accessibility can help compare interaction conditions. In RNA-protein interaction identification, the tag can support proximity-oriented capture designs when the relevant geometry and controls are validated. These application areas are described in the product dossier and should be treated as use cases rather than universal performance claims (product information).

The probe is listed as membrane-permeable and applicable to in vitro and in vivo cellular contexts. Cellular uptake does not establish uniform intracellular concentration, reaction selectivity, toxicity, or preservation of native structure. Those variables depend on cell type, exposure design, solvent composition, probe concentration, incubation duration, and downstream quenching or washing. A pilot experiment should therefore measure viability and background labeling before a large-scale study.

Why this cross-domain matters, maturity, and limitations

RNA structure probing and accessible-DNA mapping share a chemical-accessibility logic, but they are not interchangeable assays. Product information lists both RNA and single-stranded DNA applications. The CasKAS study independently supports chemical mapping of CRISPR-associated ssDNA structures, but it does not establish that N3-kethoxal reproduces every CasKAS condition or every sequencing metric. The cross-domain bridge is therefore mechanistically plausible and application-oriented, while assay maturity remains system-specific (product information; Marinov et al., 2023).

Common Pitfalls or Misconceptions

• It is not a universal nucleic-acid stain. The stated target is unpaired guanine, so paired guanine and guanine-poor regions may produce weak or absent signal.
• The azide is not the final reporter. Detection generally requires a compatible bioorthogonal click chemistry step. Probe-only and click-reagent-only controls are needed.
• A modification map is not a complete structure model. Reactivity reports chemical accessibility under the tested conditions. It does not by itself prove a single secondary or tertiary structure.
• Membrane permeability is not equivalent to validated cellular performance. Cellular uptake, toxicity, and intracellular reaction selectivity require direct testing in the chosen model.
• CasKAS is not a product performance certificate. It is a peer-reviewed method for CRISPR specificity mapping. Its findings provide context for ssDNA accessibility mapping, not a substitute for N3-kethoxal validation.

Workflow Integration & Parameters

A robust workflow treats N3-kethoxal labeling as one module in a chain: sample preparation, probe exposure, covalent marking, click conjugation, cleanup, and readout. The readout may involve sequencing, enrichment, imaging, or interaction analysis. Each module can introduce bias. Keep the biological question, structural state, and detection chemistry aligned.

Protocol Parameters

• Identity and form: Use the liquid N3-kethoxal product identified as CAS 2382756-48-9 and SKU A8793. Confirm lot documentation before preparing a new experiment (product information).
• Solvent screening: The product listing reports minimum solubilities of 94.6 mg/mL in DMSO, 24.6 mg/mL in water, and 30.4 mg/mL in ethanol. Because the public listing does not provide temperature or pH for these measurements, verify clarity and stability in the actual assay matrix before use (product information).
• Storage: Store N3-kethoxal at -20°C for optimal stability. The product information recommends short-term use when the compound is in solution form (product information).
• Controls: Include an untreated sample, a probe-exposed sample without click reagent, and a click-reagent background control. These are workflow recommendations, not numerical parameters from the reference study.
• Reaction design: Select probe concentration, exposure time, buffer, pH, temperature, and quenching conditions through a pilot matrix. Do not transfer values from an unrelated nucleic-acid assay without testing structural preservation and background.
• Click chemistry: Choose a validated azide-compatible click partner that matches the intended readout. Confirm that the click step does not create substantial nonspecific signal or alter the nucleic-acid fraction being measured.
• Cellular studies: For in vivo or cell-based work, establish uptake, viability, labeling background, and washout behavior in the specific cell model before interpreting structure-dependent changes.
• Shipping: The product logistics specify blue ice for small molecules and dry ice for modified nucleotides. Follow the current shipment documentation for the ordered material.

For practical scenario selection, the related article N3-kethoxal (SKU A8793): Scenario-Driven Solutions for Hi... emphasizes laboratory decision points and use-case questions; this article extends that perspective by separating product specifications from the independent CasKAS evidence base. The article N3-kethoxal: Mechanistic Precision and Strategic Vision f... focuses on strategic and translational framing; this article clarifies which mechanistic and numeric claims are directly supported by the product page or peer-reviewed reference.

Conclusion & Outlook

N3-kethoxal combines guanine-accessible nucleic-acid reactivity with an azide handle for downstream click chemistry. The product dossier supports its use as a membrane-permeable probe in RNA and single-stranded DNA research, including structure probing, accessible-DNA mapping, and molecular interaction studies. Its identity, solubility, purity, and storage specifications are explicitly listed by the originating company, APExBIO.

The CasKAS study shows why chemical mapping of transient ssDNA structures can answer difficult specificity questions in vitro and in vivo. The near-term value of N3-kethoxal is therefore strongest when investigators define the target structural state, use assay-matched controls, and connect the azide mark to a validated readout. The outlook is evidence-led: better adoption depends on reproducible condition reporting, orthogonal validation, and clear separation between chemical accessibility and complete structural inference.